Skip to main content
Official EU label nameGlossary entry 26489

SODIUM CHONDROITIN SULFATE

This record confirms an official common ingredient name for EU cosmetic product labelling. It does not by itself confirm that the substance is permitted, unrestricted or safe.

Global evidence snapshot

The resolved identity has matching regulatory evidence in 0 of 13 indexed market datasets: 0 country records and 0 EU Annex records. Every result and evidence gap is listed below.

0 markets with evidence
Markets checked
13
Markets with evidence
0
Evidence gaps
13
Resolved identifiers
3

Resolved substance identity

CAS:9007-28-79082-07-9
EC:232-696-9
Ingredient index records:
SODIUM CHONDROITIN SULFATE
Cosmetic functions: ANTISTATIC, HAIR CONDITIONING, SKIN CONDITIONING

Chondroitin, hydrogen sulfate

1 matched or reported name
SODIUM CHONDROITIN SULFATE

Regulatory evidence across markets

None of the 13 markets tracked here holds an imported rule under the name SODIUM CHONDROITIN SULFATE.

That is a statement about this inventory, not about the law: no imported rule is not evidence that a substance is permitted. A rule may exist under a different name, under a CAS or EC number this glossary entry does not carry, or in a dataset not yet imported.

Chemical identity and properties

PubChem 2D chemical structure for CAS 9007-28-7
CAS 9007-28-7PubChem CID 24766

Chondroitin Sulfate

Chondroitin sulfate is a glycosaminoglycan considered as a symptomatic slow-acting drug for osteoarthritis (SYSADOA). The SYSADOA status suggested a pain relief and increased joint mobility after a relative long regular administration, as well as a long-lasting effect after the end of the treatment. Chondroitin sulfate is composed of alternating 1,3-N-acetyl-β-d-galactosamine and 1,4-β-d-glucuronic acid units which bear 4-O- and/or 6-O-sulfations at the N-acetylgalactosamine units disposed of in specific patterns. Depending on the predominating disaccharide unit, it will present different biological activities. Chondroitin sulfate is sold as an OTC dietary supplement in North America and it is a prescription drug under the EMA in Europe. — DrugBank

IUPAC name
(2S,3S,4S,5R,6R)-6-[(2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-sulfooxyoxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
Molecular formula
C13H21NO15S
Molecular weight
463.37 g/mol
Exact mass
463.06319014 Da
XLogP3
-4.8
Topological polar surface area
267.0 Ų
Hydrogen-bond donors
8
Hydrogen-bond acceptors
15
Covalent units
1
Defined stereocentres
10

Also known as

Chondroitin, hydrogen sulfateCHEBI:37397(2S,3S,4S,5R,6R)-6-{[(2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-(sulfooxy)oxan-4-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid(2S,3S,4S,5R,6R)-6-(((2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-(sulfooxy)oxan-4-yl)oxy)-3,4,5-trihydroxyoxane-2-carboxylic acidRefChem:7109Chondroitine sulfateChondroitin 4-sulfate sodium saltSodium chondroitin sulfate
16 more reported names
CondrosulfChondroitinsulfate CC13H21NO15SChondroitin 4 and 6 sulfateChondronStructumGepanUropol SEINECS 246-844-5Chondroitin sulfate sodium salt from shark cartilageEpitope ID:136108UNII-7LWQ6472SPChondroitin sulfate A sodium salt(2S,3S,4S,5R,6R)-6-[[(2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-sulfooxy-4-oxanyl]oxy]-3,4,5-trihydroxy-2-oxanecarboxylic acidChondroitin Sulfate, Bovine TracheaChondroitin sulfate A sodium salt - Average MW 20,000 - 30,000
External database identifiers

Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Take this record further

Screen in a formulaOpen standalone comparison

Official source and scope

Imported from Commission Implementing Decision (EU) 2025/1175 (dataset version EU 2025/1175). The glossary supplies common ingredient names for the ingredient list required by Article 19(1)(g); it is not an approval or safety list.

Open official Decision